Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-08-16

FDA Approved: IPRATROPIUM BROMIDE — Original Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved Amneal Pharmaceuticals NY LLC's generic ipratropium bromide as an Original Application (ANDA). It is indicated for COPD-related bronchospasm and rh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)

Snippet

ORIG AP for IPRATROPIUM BROMIDE (IPRATROPIUM BROMIDE)